Squamous cell carcinoma natural history complications and prognosis: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...)
Line 1: Line 1:
{{Squamous cell carcinoma}}
{{Squamous cell carcinoma}}
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]][mailto:agovi@perfuse.org], [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]] [mailto:rgudetti@perfuse.org]
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User:Aditya Govindavarjhulla|Aditya Govindavarjhulla, M.B.B.S.]][mailto:agovi@wikidoc.org], [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]] [mailto:ravitheja.g@gmail.com]


== Natural History ==
== Natural History ==

Revision as of 18:12, 2 November 2012

Squamous cell carcinoma of the skin Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous cell carcinoma of the skin from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma natural history complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma natural history complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma natural history complications and prognosis

CDC on Squamous cell carcinoma natural history complications and prognosis

Squamous cell carcinoma natural history complications and prognosis in the news

Blogs on Squamous cell carcinoma natural history complications and prognosis

Directions to Hospitals Treating Squamous cell carcinoma of the skin

Risk calculators and risk factors for Squamous cell carcinoma natural history complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S.[2], Raviteja Guddeti, M.B.B.S. [3]

Natural History

Once Squamous cell carcinoma (SCC) develops on the skin it grows slowly. If neglected and once it reaches the size of 2 cm and more it is three times more likely to spread to other areas than the smaller lesions. Usual size ranges from 1 cm to 5 cm. It is the mechanical interference of this fungiform exophytic lesion that brings it to the notice of the patient or the clinician.

Complications

When treated, early squamous cell carcinoma is completely curable by 95% - 98%. If left untreated it has the tendency to spread to other areas like lymph nodes, internal organs. Immunosuppressed patients have a far more tendency to develop aggressive form of the tumor. Other possible complications of this tumor are skin abscesses and Cellulitis. The primary complication of this lesion once treated is recurrence, which usually occurs with in the first year after resection.

Prognosis

This lesion has a cure rate of 95% - 98%. But once the lesion spreads to other regions beyond skin, like lymph nodes and internal organs less than half of the patients live five years. A sub set of SCC carries the risk of local recurrence, nodal or distant metastasis (usually to the lungs) and eventually death. Tumors in this sub set are termed high risk SCC. Tumor related factors in high risk SCC are

  • Tumor location (ie. lips, ears, anogenital region, within a scar or chronic wound) - Metastatic rates for lesions on lips (13.7%) and ears (11.%) are particularly high. The 5 year survival rates after metastasis from these sites are usually range from 25% - 40%. Primary SCCs on the trunk and limbs are associated with a metastatic rate of 4.9%. Marjolin's ulcer, a sub type of SCC behaves aggressively with a metastatic rate of 35%. Similarly SCCs arising from injured and chronically diseased skin have a metastatic rate of 40%.
  • Tumor size greater than 2 cm (1.5 cm for lesions on ear or lip) - Lesions less than 2 cm have a metastatic potential of 9.1% whereas in those of size more than 2 cm the rates spike up to 30.3%.
  • Invasion to subcutaneous fat - less than 2 mm - 95% survival rate, from 2-9 mm - 80% survival rate, more than 9 mm - 65% survival rate.
  • Poorly differentiated cells
  • Recurrent tumor
  • Perineural involvement - the metastatic rate in such involvement can reach 45%. The degree of nerve involvement likely has a major impact on the prognosis. [1]

The 3 year disease specific survival rate for SCC is 85%. The figure reaches 100% in lesions with no high risk factors. The overall survival rates drop down drastically once the lesion spreads to lymph nodes and internal organs.


References

  1. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. Jun 1992;26(6):976-90


de:Plattenepithelkarzinom he:קרצינומת תאי קשקש nl:Plaveiselcelcarcinoom


Template:WikiDoc Sources